Literature DB >> 30739562

Comparing clinical parameters of abnormal and normal fasting blood glucose in benign prostatic hyperplasia patients.

Ming-Juan Zhao1,2, Qiao Huang1, Xing-Huan Wang1,3, Xuan-Yi Ren4, Ying-Hui Jin1, Xian-Tao Zeng1,3.   

Abstract

OBJECTIVE: To investigate the correlation of clinical measurements on normal and abnormal fasting blood glucose (FBG) with benign prostatic hyperplasia (BPH).
METHODS: From September 2016 to January 2018, 771 BPH patients were enrolled for further selection. The eligible patients were divided into normal FBG, impaired fasting glucose (IFG), and high risk of type 2 diabetes mellitus (HR-T2DM) groups. Then, relevant parameters were compared among these three groups using Pearson's correlation coefficient.
RESULTS: Finally including 443 patients with normal FBG, 113 with IFG and 56 with HR-T2DM. Height, weight, body mass index, smoking status, hemoglobin, serum Na+, serum Cl-, and serum Ca2+ were significantly different between normal and abnormal FBG groups. In IFG/HR-T2DM group, obviously connections were demonstrated for weight with prostate volume (PV), for serum Na+, PV, and serum Cl- with total prostate-specific antigen (t-PSA), for FBG with international prostate symptom score (IPSS). In normal FBG group, significant correlations of age, weight, body mass index, hemoglobin, and serum Ca2+ with PV, of age, systolic blood pressure, PV, and serum Cl- with t-PSA; and of FBG, hemoglobin, and serum Na+ with IPSS were also observed.
CONCLUSIONS: Our study suggests that FBG level probably plays an important role in BPH.

Entities:  

Keywords:  Benign prostatic hyperplasia; diabetes mellitus; fasting blood glucose; impaired fasting glucose; international prostate symptom score; prostate specific antigen; prostate volume

Mesh:

Substances:

Year:  2019        PMID: 30739562     DOI: 10.1080/13685538.2019.1570493

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  6 in total

1.  Using Haemocoagulase Agkistrodon in Patients Undergoing Transurethral Plasmakinetic Resection of the Prostate: A Pilot, Real-World, and Propensity Score-Matched Study.

Authors:  Cong Zhu; Lan Yang; Hao Zi; Bing-Hui Li; Qiao Huang; Meng-Xin Lu; Xiao-Dong Li; Xuan-Yi Ren; Hua Tao; Hankun Hu; Xian-Tao Zeng
Journal:  Biomed Res Int       Date:  2022-06-22       Impact factor: 3.246

2.  Fasting blood glucose level and hypertension risk in aging benign prostatic hyperplasia patients.

Authors:  Hao Zi; Xue-Jun Wang; Ming-Juan Zhao; Qiao Huang; Xing-Huan Wang; Xian-Tao Zeng
Journal:  Aging (Albany NY)       Date:  2019-07-03       Impact factor: 5.682

3.  Periodontitis Exacerbates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress and Inflammation.

Authors:  Cheng Fang; Lan Wu; Ming-Juan Zhao; Tong Deng; Jia-Min Gu; Xing-Pei Guo; Cheng Li; Weiguang Li; Xian-Tao Zeng
Journal:  Oxid Med Cell Longev       Date:  2021-10-18       Impact factor: 6.543

4.  Can Routine Blood and Urine Parameters Reveal Clues to Detect Bladder Cancer? A Case-Control Study.

Authors:  Dan-Qi Wang; Juan Shuai; Hang Zheng; Zhong-Qiang Guo; Qiao Huang; Xiao-Feng Xu; Xiao-Dong Li; Hao Zi; Dao-Jing Ming; Xuan-Yi Ren; Xian-Tao Zeng
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

5.  Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats.

Authors:  Lu-Yao Li; Jie Han; Lan Wu; Cheng Fang; Wei-Guang Li; Jia-Min Gu; Tong Deng; Chang-Jiang Qin; Jia-Yan Nie; Xian-Tao Zeng
Journal:  Mil Med Res       Date:  2022-03-28

6.  Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study.

Authors:  Lan Wu; Bing-Hui Li; Yun-Yun Wang; Chao-Yang Wang; Hao Zi; Hong Weng; Qiao Huang; You-Jia Zhu; Xian-Tao Zeng
Journal:  Mil Med Res       Date:  2019-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.